New blood test could replace risky prenatal procedures for genetic diseases

NCT ID NCT06147414

First seen Jan 22, 2026 · Last updated Apr 28, 2026 · Updated 16 times

Summary

This study aims to see if a simple blood test from the mother can accurately diagnose single-gene disorders (like sickle cell disease or cystic fibrosis) in the fetus, starting as early as 9 weeks of pregnancy. The test looks at fetal DNA found in the mother's blood, which avoids the miscarriage risk of traditional invasive tests. Researchers will enroll 550 pregnant women to compare the blood test results with standard diagnostic methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique

    RECRUITING

    Paris, 75014, France

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.